VANGUARD GROUP INC - CONATUS PHARMACEUTICALS INC ownership

CONATUS PHARMACEUTICALS INC's ticker is CNAT and the CUSIP is 20600T108. A total of 39 filers reported holding CONATUS PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of CONATUS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$407,000
-24.6%
1,312,173
-2.8%
0.00%
Q4 2019$540,000
+27.1%
1,350,5260.0%0.00%
Q3 2019$425,000
-12.4%
1,350,526
-27.5%
0.00%
Q2 2019$485,000
-72.6%
1,861,987
+13.6%
0.00%
Q1 2019$1,770,000
+73.9%
1,638,895
+178.7%
0.00%
Q4 2018$1,018,000
-87.1%
588,136
-56.7%
0.00%
Q3 2018$7,886,000
+35.5%
1,359,582
+0.0%
0.00%
Q2 2018$5,818,000
-28.7%
1,359,282
-2.2%
0.00%
Q1 2018$8,158,000
+26.9%
1,389,687
-0.1%
0.00%
Q4 2017$6,429,000
-3.7%
1,391,559
+14.5%
0.00%
Q3 2017$6,674,000
+15.1%
1,215,678
+20.7%
0.00%
Q2 2017$5,800,000
+31.0%
1,006,890
+31.2%
0.00%
Q1 2017$4,428,000
+111.4%
767,517
+93.1%
0.00%
Q4 2016$2,095,000
+84.3%
397,544
-30.1%
0.00%
Q3 2016$1,137,000
+22.9%
568,751
+26.7%
0.00%
Q2 2016$925,000
-0.3%
448,938
+3.5%
0.00%
Q1 2016$928,000
-20.2%
433,638
+7.4%
0.00%
Q4 2015$1,163,000
-99.3%
403,838
-92.3%
0.00%
-100.0%
Q3 2015$163,003,000
+9631.5%
5,224,086
+1506.8%
0.01%
Q2 2015$1,675,000
+8.2%
325,120
+49.5%
0.00%
Q1 2015$1,548,000
+5.4%
217,453
+3.6%
0.00%
Q4 2014$1,469,000
+33.1%
209,853
+16.4%
0.00%
Q3 2014$1,104,000
-2.9%
180,353
+44.5%
0.00%
Q2 2014$1,137,000
+3.8%
124,804
-7.3%
0.00%
Q1 2014$1,095,000
+119.9%
134,564
+74.1%
0.00%
Q4 2013$498,000
-18.8%
77,272
+26.7%
0.00%
Q3 2013$613,00061,0120.00%
Other shareholders
CONATUS PHARMACEUTICALS INC shareholders Q4 2013
NameSharesValueWeighting ↓
Kalos Management, Inc. 47,500$12,0000.01%
Virtu Financial LLC 94,842$25,0000.00%
ACADIAN ASSET MANAGEMENT LLC 467,425$121,0000.00%
REILLY FINANCIAL ADVISORS, LLC 22,011$6,0000.00%
A.R.T. Advisors, LLC 60,430$16,0000.00%
GOLDMAN SACHS GROUP INC 25,350$7,0000.00%
MORGAN STANLEY 1,019$00.00%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 24,900$6,0000.00%
WOLVERINE TRADING, LLC 30,900$8,0000.00%
WOLVERINE TRADING, LLC 26,779$7,0000.00%
View complete list of CONATUS PHARMACEUTICALS INC shareholders